<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="70642">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02092441</url>
  </required_header>
  <id_info>
    <org_study_id>BAMC 395266-1</org_study_id>
    <nct_id>NCT02092441</nct_id>
  </id_info>
  <brief_title>Inhalation Intervention for Nausea in the Emergency Department</brief_title>
  <official_title>Inhalation Intervention for Nausea in the Emergency Department</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brooke Army Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Brooke Army Medical Center</source>
  <oversight_info>
    <authority>United States: Federal Government</authority>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to investigate if inhaling the scent of a typical medical alcohol prep pad
      will alleviate nausea as compared to a identically packaged normal saline prep pad for the
      Emergency Department patient with nausea.  The study length will be 10 minutes long.  The
      subjects will take several deep nasal inhalations at the 0, 2, 5 minute marks.  Level of
      nausea will be recorded during these times and at 10 minutes.  The investigators will also
      assess satisfaction of the intervention.  As in previous post operative unit studies,the
      hypothesis is that there will a significant difference in levels of nausea between the
      alcohol pad group versus the normal saline pad group.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>Significant change in level of nausea.</measure>
    <time_frame>Intial assessment, 2 minute, 5 minute, 10 minute.</time_frame>
    <safety_issue>No</safety_issue>
    <description>Primary outcome is significant change of nausea and vomiting is defined decrease of 3 on a 0-10 Verbal Numerical Response Scale (VNRS).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to effect for significant change in nausea level</measure>
    <time_frame>Initial assesment, 2 minute, 5 minute, and 10 minute</time_frame>
    <safety_issue>No</safety_issue>
    <description>Secondary outcomes are time to effect, and satisfaction of intervention.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Secondary outcome of satisfaction.</measure>
    <time_frame>2 minute, 5 minute, and 10 minute</time_frame>
    <safety_issue>No</safety_issue>
    <description>Patient satisfaction of smelling prep pad to alleviate nausea.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">72</enrollment>
  <condition>Nausea</condition>
  <condition>Vomiting</condition>
  <arm_group>
    <arm_group_label>Alcohol prep pad group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>isopropyl alcohol prep pad</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal Saline prep pad</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>normal saline prep pad</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Alcohol prep pad group</intervention_name>
    <description>study group vs placebo group</description>
    <arm_group_label>Alcohol prep pad group</arm_group_label>
    <other_name>subjects inhale scent of randomized, blinded prep pads</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo Normal Saline prep pad</intervention_name>
    <arm_group_label>Normal Saline prep pad</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age range of 18-65 years of age

          -  complaint of nausea and or vomiting

          -  ability to breathe through nose

          -  ability to read and write English

        Exclusion Criteria:

          -  allergy to isopropyl alcohol

          -  pregnancy or pregnancy status unknown to subject.  Pregnancy test only if part of
             clinical course.

          -  recent upper respiratory infection

          -  recent intake of cefoperazone, disulfiram, or metronidazole or any other medications
             that are known produce nausea when exposed to alcohol.

          -  use of antiemetic or psychoactive drug within 24 hours

          -  alcohol abuse

          -  nicotine within last 4 hrs
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kenneth L Beadle, MPAS, BS</last_name>
    <role>Principal Investigator</role>
    <affiliation>BAMC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Curtis J Hunter, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>BAMC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kenneth L Beadle, MPAS, BS</last_name>
    <phone>(850) 687-9850</phone>
    <email>kenneth.l.beadle.mil@mil.mail</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Antonia R Helbling, M.D.</last_name>
    <phone>(210) 834-8068</phone>
    <email>toni.helbling@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Emergency Department, Brooke Army Medical Center</name>
      <address>
        <city>Fort Sam Houston</city>
        <state>Texas</state>
        <zip>78234</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Burleigh-Flayer HD, Gill MW, Strother DE, Masten LW, McKee RH, Tyler TR, Gardiner T. Isopropanol 13-week vapor inhalation study in rats and mice with neurotoxicity evaluation in rats. Fundam Appl Toxicol. 1994 Oct;23(3):421-8.</citation>
    <PMID>7835543</PMID>
  </reference>
  <reference>
    <citation>Gill MW, Burleigh-Flayer HD, Strother DE, Masten LW, McKee RH, Tyler TR, Gardiner TH. Isopropanol: acute vapor inhalation neurotoxicity study in rats. J Appl Toxicol. 1995 Mar-Apr;15(2):77-84.</citation>
    <PMID>7782562</PMID>
  </reference>
  <reference>
    <citation>Burleigh-Flayer H, Garman R, Neptun D, Bevan C, Gardiner T, Kapp R, Tyler T, Wright G. Isopropanol vapor inhalation oncogenicity study in Fischer 344 rats and CD-1 mice. Fundam Appl Toxicol. 1997 Apr;36(2):95-111.</citation>
    <PMID>9143479</PMID>
  </reference>
  <reference>
    <citation>Cotton JW, Rowell LR, Hood RR, Pellegrini JE. A comparative analysis of isopropyl alcohol and ondansetron in the treatment of postoperative nausea and vomiting from the hospital setting to the home. AANA J. 2007 Feb;75(1):21-6.</citation>
    <PMID>17304779</PMID>
  </reference>
  <reference>
    <citation>Winston AW, Rinehart RS, Riley GP, Vacchiano CA, Pellegrini JE. Comparison of inhaled isopropyl alcohol and intravenous ondansetron for treatment of postoperative nausea. AANA J. 2003 Apr;71(2):127-32.</citation>
    <PMID>12776641</PMID>
  </reference>
  <reference>
    <citation>Pellegrini J, DeLoge J, Bennett J, Kelly J. Comparison of inhalation of isopropyl alcohol vs promethazine in the treatment of postoperative nausea and vomiting (PONV) in patients identified as at high risk for developing PONV. AANA J. 2009 Aug;77(4):293-9.</citation>
    <PMID>19731848</PMID>
  </reference>
  <reference>
    <citation>Wang SM, Hofstadter MB, Kain ZN. An alternative method to alleviate postoperative nausea and vomiting in children. J Clin Anesth. 1999 May;11(3):231-4.</citation>
    <PMID>10434220</PMID>
  </reference>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 19, 2014</lastchanged_date>
  <firstreceived_date>March 18, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brooke Army Medical Center</investigator_affiliation>
    <investigator_full_name>Kenneth L Beadle</investigator_full_name>
    <investigator_title>Major, USAF, BSC</investigator_title>
  </responsible_party>
  <keyword>Nausea</keyword>
  <keyword>Vomiting</keyword>
  <keyword>Antiemetic</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Respiratory Aspiration</mesh_term>
    <mesh_term>Emergencies</mesh_term>
    <mesh_term>Nausea</mesh_term>
    <mesh_term>Vomiting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Ethanol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
